Teva Pharmaceutical Industries (TEVA) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Net Income Attributable to Noncontrolling Interests of $1 million for Q3 2026, unchanged from $1 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Income Attributable to Noncontrolling Interests at Teva Pharmaceutical Industries was $2 million; for FY2025, it came in at $7 million.
- In prior years, Teva Pharmaceutical Industries' Net Income Attributable to Noncontrolling Interests was -$320 million in FY2024, -$56 million in FY2023, -$53 million in FY2022 and $39 million in FY2021.
- Quarterly Net Income Attributable to Noncontrolling Interests has run from a low of -$280 million in Q1 2024 to a high of $47 million in Q3 2024 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Teva Pharmaceutical Industries | 49.58 Bn | 34.55 Bn | 2.44 Bn | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | -58.00 Mn |
| Sep 30, 2024 | 47.00 Mn |
| Jun 30, 2024 | -29.00 Mn |
| Mar 31, 2024 | -280.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | -35.00 Mn |
| Mar 31, 2023 | -33.00 Mn |
| Dec 31, 2022 | -32.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | -27.00 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 11.00 Mn |
| Jun 30, 2021 | 14.00 Mn |
| Mar 31, 2021 | 7.00 Mn |
| Dec 31, 2020 | 12.00 Mn |
API Access
Teva Pharmaceutical Industries Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();